Cisapride
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Cisapride
Description :
Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].Product Name Alternative :
R 51619; (±) -CisapridUNSPSC :
12352005Hazard Statement :
H315, H319, H320Target :
5-HT Receptor; Potassium ChannelType :
Reference compoundRelated Pathways :
GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal SignalingApplications :
Neuroscience-NeuromodulationField of Research :
Neurological DiseaseAssay Protocol :
https://www.medchemexpress.com/Cisapride.htmlPurity :
99.87Solubility :
DMSO : 100 mg/mL (ultrasonic) |H2O : < 0.1 mg/mLSmiles :
ClC1=C(N)C=C(OC)C(C(N[C@H]2[C@@H](OC)CN(CCCOC3=CC=C(F)C=C3)CC2)=O)=C1Molecular Formula :
C23H29ClFN3O4Molecular Weight :
465.95Precautions :
H315, H319, H320References & Citations :
[1]Toga, T., Y. Kohmura, and R. Kawatsu, The 5-HT (4) agonists cisapride, mosapride, and CJ-033466, a Novel potent compound, exhibit different human ether-a-go-go-related gene (hERG) -blocking activities. J Pharmacol Sci, 2007. 105 (2) : p. 207-10.|[2]Sung, K.W. and S.J. Hahn, Effect of mosapride on Kv4.3 potassium channels expressed in CHO cells. Naunyn Schmiedebergs Arch Pharmacol, 2013. 386 (10) : p. 905-16.|[3]Mine, Y, et al. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. J Pharmacol Exp Ther, 1997. 283 (3) : p. 1000-8.|[4]Motavallian, A, et al., Does Cisapride, as a 5HT (4) Receptor Agonist, Aggravate the Severity of TNBS-Induced Colitis in Rat. Gastroenterol Res Pract, 2012. 2012: p. 362536.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Reference compound1Clinical Information :
LaunchedIsoform :
Apolipoprotein DCAS Number :
[81098-60-4]

